Newron Pharmaceuticals
NWRN.SW
#8312
Rank
A$0.29 B
Marketcap
$15.21
Share price
2.42%
Change (1 day)
12.50%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.72

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.72. In 2023 the company made an earnings per share (EPS) of -$1.72 a decrease over its 2022 EPS that were of -$1.68.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.722.03%
2022-$1.6815.39%
2021-$1.46-31.32%
2020-$2.1214.74%
2019-$1.8536.6%
2018-$1.35159.87%
2017-$0.52-67.81%
2016-$1.62-39.24%
2015-$2.66107.61%
2014-$1.2815.8%
2013-$1.11119.91%
2012-$0.50-66.51%
2011-$1.50-71.49%
2010-$5.28-10.83%
2009-$5.9242.06%
2008-$4.1756.53%
2007-$2.66-52.84%
2006-$5.64-188.53%
2005$6.37